Evaluating Diabetes Drug Targets for Vascular Dementia Prevention Using Drug Target Mendelian Randomisation

More on Vascular dementia

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• COVID-19 tied to higher dementia risk in older adults with diabetes

  Frontiers in Aging Neuroscience · 4 Oct 2026

• GLP-1 receptor agonists link to lower stroke and Alzheimer risk

  Neurology Genetics · 4 Oct 2026

• Statins cut Alzheimer's risk but raise other dementia risks

  Journal of Alzheimer's Disease Reports · 4 Oct 2026